Literature DB >> 15652419

Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue.

Armin Alaedini1, Norman Latov.   

Abstract

Neurological sequela of chronic Lyme disease include encephalopathy, myelopathy and peripheral neuropathy. These have generally been attributed to either persistent infection or pathogen-induced autoimmunity. In this study, we investigated the presence of cross-reactive human neural epitopes that share amino acid sequences with Borrelia burgdorferi OspA protein. Sequence similarity analysis was carried out by searching known cDNA sequences from brain tissue. The cDNA database search yielded three sequences that were identical to sequences in OspA. Corresponding peptides were synthesized and antibodies were generated against them in rabbits. Antibodies against two of the homologous OspA peptides were found to react with neurons in human brain, spinal cord and dorsal root ganglia by immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652419     DOI: 10.1016/j.jneuroim.2004.10.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Texas Occurrence of Lyme Disease and Its Neurological Manifestations.

Authors:  Jad A Dandashi; Damir Nizamutdinov; Samantha Dayawansa; Ekokobe Fonkem; Jason H Huang
Journal:  J Neuroinfect Dis       Date:  2016-06-09

2.  Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.

Authors:  Keith O Strother; Emir Hodzic; Stephen W Barthold; Aravinda M de Silva
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

3.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

Review 4.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 5.  The pathogenesis of lyme neuroborreliosis: from infection to inflammation.

Authors:  Tobias A Rupprecht; Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

6.  Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis.

Authors:  Yu-Fan Hsieh; Han-Wen Liu; Tsai-Ching Hsu; James C-C Wei; Chien-Ming Shih; Peter J Krause; Gregory J Tsay
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

7.  Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015).

Authors:  L K Johnstone; J B Engiles; H Aceto; V Buechner-Maxwell; T Divers; R Gardner; R Levine; N Scherrer; D Tewari; J Tomlinson; A L Johnson
Journal:  J Vet Intern Med       Date:  2016-06-21       Impact factor: 3.333

8.  Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis.

Authors:  Lilija Kovalchuka; Svetlana Cvetkova; Julija Trofimova; Jelena Eglite; Sandra Gintere; Irina Lucenko; Barbara Oczko-Grzesik; Ludmila Viksna; Angelika Krumina
Journal:  Int J Environ Res Public Health       Date:  2016-12-01       Impact factor: 3.390

9.  Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease.

Authors:  Maryalice Citera; Phyllis R Freeman; Richard I Horowitz
Journal:  Int J Gen Med       Date:  2017-09-04

10.  Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.

Authors:  Aristo Vojdani; Frank Hebroni; Yaniv Raphael; Jonathan Erde; Bernard Raxlen
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.